ID   DPYL3_HUMAN             Reviewed;         570 AA.
AC   Q14195; B3SXQ8; Q93012;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-APR-2017, entry version 164.
DE   RecName: Full=Dihydropyrimidinase-related protein 3;
DE            Short=DRP-3;
DE   AltName: Full=Collapsin response mediator protein 4;
DE            Short=CRMP-4;
DE   AltName: Full=Unc-33-like phosphoprotein 1;
DE            Short=ULIP-1;
GN   Name=DPYSL3; Synonyms=CRMP4, DRP3, ULIP, ULIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8973361; DOI=10.1016/S0378-1119(96)00445-3;
RA   Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M.;
RT   "A novel gene family defined by human dihydropyrimidinase and three
RT   related proteins with differential tissue distribution.";
RL   Gene 180:157-163(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9115293; DOI=10.1074/jbc.272.18.12195;
RA   Gaetano C., Matsuo T., Thiele C.J.;
RT   "Identification and characterization of a retinoic acid-regulated
RT   human homologue of the unc-33-like phosphoprotein gene (hUlip) from
RT   neuroblastoma cells.";
RL   J. Biol. Chem. 272:12195-12201(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LCRMP-4).
RA   Pan S.-H., Hong T.-M., Chao Y.-C., Yang S.-C., Yang P.-C.;
RT   "Long form collapsin response mediator protein-1 (LCRMP-1) is a novel
RT   invasion enhancer: counter-regulation of cancer cell invasion by
RT   LCRMP-1 and CRMP-1.";
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 24-56; 82-122; 131-157; 239-254; 259-268; 346-368;
RP   375-397; 401-418; 424-440; 452-480; 488-511 AND 532-550, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 (ISOFORM LCRMP-4),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   PHOSPHORYLATION AT SER-522 BY DYRK2, AND PHOSPHORYLATION AT THR-509;
RP   THR-514 AND SER-518 BY GSK3.
RX   PubMed=16611631; DOI=10.1074/jbc.M513344200;
RA   Cole A.R., Causeret F., Yadirgi G., Hastie C.J., McLauchlan H.,
RA   McManus E.J., Hernandez F., Eickholt B.J., Nikolic M., Sutherland C.;
RT   "Distinct priming kinases contribute to differential regulation of
RT   collapsin response mediator proteins by glycogen synthase kinase-3 in
RT   vivo.";
RL   J. Biol. Chem. 281:16591-16598(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-259; THR-509; THR-514
RP   AND SER-522, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102
RP   (ISOFORM LCRMP-4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509 AND SER-522,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-102 (ISOFORM LCRMP-4),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Necessary for signaling by class 3 semaphorins and
CC       subsequent remodeling of the cytoskeleton. Plays a role in axon
CC       guidance, neuronal growth cone collapse and cell migration (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homotetramer, and heterotetramer with CRMP1, DPYSL2,
CC       DPYSL4 or DPYSL5. Interacts with synaptic vesicle protein 2 and
CC       SH3A domain of intersectin. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q96AP0:ACD; NbExp=2; IntAct=EBI-1104726, EBI-717666;
CC       Q14194:CRMP1; NbExp=5; IntAct=EBI-10232496, EBI-473101;
CC       Q16555:DPYSL2; NbExp=7; IntAct=EBI-10232496, EBI-1104711;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell projection,
CC       growth cone {ECO:0000250}. Note=Colocalizes with synaptic vesicle
CC       protein 2 in the central region of the growth cone. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14195-1; Sequence=Displayed;
CC       Name=LCRMP-4;
CC         IsoId=Q14195-2; Sequence=VSP_042546;
CC         Note=Contains a phosphoserine at position 102.
CC         {ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:21406692,
CC         ECO:0000244|PubMed:24275569};
CC   -!- TISSUE SPECIFICITY: Mainly expressed in heart and skeletal muscle.
CC       Also strongly expressed in fetal brain and spinal cord.
CC   -!- PTM: Phosphorylation on Ser-522 by DYRK2 promotes subsequent
CC       phosphorylation on Thr-509, Thr-514 and Ser-518 by GSK3.
CC       {ECO:0000269|PubMed:16611631}.
CC   -!- SIMILARITY: Belongs to the DHOase family.
CC       Hydantoinase/dihydropyrimidinase subfamily. {ECO:0000305}.
CC   -!- CAUTION: Lacks most of the conserved residues that are essential
CC       for binding the metal cofactor and hence for dihydropyrimidinase
CC       activity. Its enzyme activity is therefore unsure. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D78014; BAA11192.1; -; mRNA.
DR   EMBL; Y07818; CAA69153.1; -; mRNA.
DR   EMBL; EU007906; ABV80252.1; -; mRNA.
DR   EMBL; AC011373; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS43381.1; -. [Q14195-1]
DR   CCDS; CCDS56387.1; -. [Q14195-2]
DR   PIR; JC5318; JC5318.
DR   RefSeq; NP_001184223.1; NM_001197294.1. [Q14195-2]
DR   RefSeq; NP_001378.1; NM_001387.2. [Q14195-1]
DR   UniGene; Hs.519659; -.
DR   PDB; 4BKN; X-ray; 2.10 A; A/B=1-570.
DR   PDB; 4CNS; X-ray; 2.40 A; A/B/C/D=13-490.
DR   PDB; 4CNT; X-ray; 2.65 A; A/B/C/D=1-570.
DR   PDB; 4CNU; X-ray; 2.80 A; A/B=1-570.
DR   PDBsum; 4BKN; -.
DR   PDBsum; 4CNS; -.
DR   PDBsum; 4CNT; -.
DR   PDBsum; 4CNU; -.
DR   ProteinModelPortal; Q14195; -.
DR   SMR; Q14195; -.
DR   BioGrid; 108143; 32.
DR   IntAct; Q14195; 10.
DR   STRING; 9606.ENSP00000343690; -.
DR   MEROPS; M38.976; -.
DR   iPTMnet; Q14195; -.
DR   PhosphoSitePlus; Q14195; -.
DR   BioMuta; DPYSL3; -.
DR   DMDM; 3122050; -.
DR   REPRODUCTION-2DPAGE; Q14195; -.
DR   UCD-2DPAGE; Q14195; -.
DR   EPD; Q14195; -.
DR   MaxQB; Q14195; -.
DR   PaxDb; Q14195; -.
DR   PeptideAtlas; Q14195; -.
DR   PRIDE; Q14195; -.
DR   DNASU; 1809; -.
DR   Ensembl; ENST00000343218; ENSP00000343690; ENSG00000113657. [Q14195-2]
DR   Ensembl; ENST00000398514; ENSP00000381526; ENSG00000113657. [Q14195-1]
DR   GeneID; 1809; -.
DR   KEGG; hsa:1809; -.
DR   UCSC; uc003lon.2; human. [Q14195-1]
DR   CTD; 1809; -.
DR   DisGeNET; 1809; -.
DR   GeneCards; DPYSL3; -.
DR   HGNC; HGNC:3015; DPYSL3.
DR   HPA; HPA010948; -.
DR   MIM; 601168; gene.
DR   neXtProt; NX_Q14195; -.
DR   OpenTargets; ENSG00000113657; -.
DR   PharmGKB; PA27473; -.
DR   eggNOG; KOG2584; Eukaryota.
DR   eggNOG; COG0044; LUCA.
DR   GeneTree; ENSGT00760000119241; -.
DR   HOGENOM; HOG000219145; -.
DR   HOVERGEN; HBG000806; -.
DR   InParanoid; Q14195; -.
DR   OMA; GFHLMIS; -.
DR   OrthoDB; EOG091G05F3; -.
DR   PhylomeDB; Q14195; -.
DR   TreeFam; TF314706; -.
DR   Reactome; R-HSA-399956; CRMPs in Sema3A signaling.
DR   SIGNOR; Q14195; -.
DR   ChiTaRS; DPYSL3; human.
DR   GeneWiki; DPYSL3; -.
DR   GenomeRNAi; 1809; -.
DR   PRO; PR:Q14195; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113657; -.
DR   CleanEx; HS_DPYSL3; -.
DR   ExpressionAtlas; Q14195; baseline and differential.
DR   Genevisible; Q14195; HS.
DR   GO; GO:0044297; C:cell body; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0070382; C:exocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0031941; C:filamentous actin; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB.
DR   GO; GO:0031005; F:filamin binding; IPI:WormBase.
DR   GO; GO:0016810; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; IEA:InterPro.
DR   GO; GO:0017124; F:SH3 domain binding; ISS:UniProtKB.
DR   GO; GO:0051764; P:actin crosslink formation; ISS:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; ISS:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; ISS:UniProtKB.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 2.30.40.10; -; 1.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR030628; DRP3.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   PANTHER; PTHR11647:SF86; PTHR11647:SF86; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Methylation;
KW   Nitration; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    570       Dihydropyrimidinase-related protein 3.
FT                                /FTId=PRO_0000165917.
FT   MOD_RES      32     32       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q16555}.
FT   MOD_RES     101    101       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q14194}.
FT   MOD_RES     102    102       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q14194}.
FT   MOD_RES     258    258       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     316    316       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:P97427}.
FT   MOD_RES     431    431       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q62188}.
FT   MOD_RES     499    499       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q62188}.
FT   MOD_RES     509    509       Phosphothreonine; by GSK3.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:16611631}.
FT   MOD_RES     514    514       Phosphothreonine; by GSK3.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:16611631}.
FT   MOD_RES     518    518       Phosphoserine; by GSK3.
FT                                {ECO:0000269|PubMed:16611631}.
FT   MOD_RES     522    522       Phosphoserine; by DYRK2.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:16611631}.
FT   MOD_RES     536    536       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62188}.
FT   MOD_RES     539    539       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62188}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62188}.
FT   MOD_RES     563    563       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:O08553}.
FT   VAR_SEQ       1     13       MSYQGKKNIPRIT -> MASGRRGWDSSHEDDLPVYLARPG
FT                                TTDQVPRQKYGGMFCNVEGAFESKTLDFDALSVGQRGAKTP
FT                                RSGQGSDRGSGSRPGIEGDTPRRGQGREESREPAPASPAPA
FT                                GVEIRSATGKEVLQNLGPKDK (in isoform LCRMP-
FT                                4). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_042546.
FT   VARIANT     442    442       A -> S (in dbSNP:rs2304044).
FT                                /FTId=VAR_020485.
FT   CONFLICT     49     49       L -> V (in Ref. 2; CAA69153).
FT                                {ECO:0000305}.
FT   CONFLICT    142    142       T -> A (in Ref. 2; CAA69153).
FT                                {ECO:0000305}.
FT   STRAND       17     25       {ECO:0000244|PDB:4BKN}.
FT   STRAND       30     38       {ECO:0000244|PDB:4BKN}.
FT   STRAND       41     48       {ECO:0000244|PDB:4BKN}.
FT   STRAND       56     59       {ECO:0000244|PDB:4BKN}.
FT   STRAND       64     67       {ECO:0000244|PDB:4BKN}.
FT   STRAND       69     74       {ECO:0000244|PDB:4BKN}.
FT   HELIX        89     98       {ECO:0000244|PDB:4BKN}.
FT   STRAND      101    108       {ECO:0000244|PDB:4BKN}.
FT   HELIX       116    130       {ECO:0000244|PDB:4BKN}.
FT   STRAND      132    141       {ECO:0000244|PDB:4BKN}.
FT   HELIX       146    158       {ECO:0000244|PDB:4BKN}.
FT   STRAND      163    168       {ECO:0000244|PDB:4BKN}.
FT   TURN        171    174       {ECO:0000244|PDB:4BKN}.
FT   HELIX       178    191       {ECO:0000244|PDB:4BKN}.
FT   STRAND      194    198       {ECO:0000244|PDB:4BKN}.
FT   HELIX       202    214       {ECO:0000244|PDB:4BKN}.
FT   HELIX       221    225       {ECO:0000244|PDB:4BKN}.
FT   HELIX       229    245       {ECO:0000244|PDB:4BKN}.
FT   STRAND      250    255       {ECO:0000244|PDB:4BKN}.
FT   HELIX       258    270       {ECO:0000244|PDB:4BKN}.
FT   STRAND      274    279       {ECO:0000244|PDB:4BKN}.
FT   HELIX       280    284       {ECO:0000244|PDB:4BKN}.
FT   HELIX       287    291       {ECO:0000244|PDB:4BKN}.
FT   HELIX       295    300       {ECO:0000244|PDB:4BKN}.
FT   HELIX       313    322       {ECO:0000244|PDB:4BKN}.
FT   HELIX       338    341       {ECO:0000244|PDB:4BKN}.
FT   HELIX       342    344       {ECO:0000244|PDB:4BKN}.
FT   HELIX       348    350       {ECO:0000244|PDB:4BKN}.
FT   TURN        358    360       {ECO:0000244|PDB:4BKN}.
FT   HELIX       361    369       {ECO:0000244|PDB:4BKN}.
FT   TURN        370    373       {ECO:0000244|PDB:4BKN}.
FT   HELIX       377    384       {ECO:0000244|PDB:4BKN}.
FT   HELIX       386    391       {ECO:0000244|PDB:4BKN}.
FT   TURN        395    397       {ECO:0000244|PDB:4BKN}.
FT   STRAND      409    419       {ECO:0000244|PDB:4BKN}.
FT   TURN        422    424       {ECO:0000244|PDB:4BKN}.
FT   STRAND      426    428       {ECO:0000244|PDB:4BKN}.
FT   TURN        433    436       {ECO:0000244|PDB:4BKN}.
FT   STRAND      438    448       {ECO:0000244|PDB:4BKN}.
FT   STRAND      451    455       {ECO:0000244|PDB:4BKN}.
FT   HELIX       476    487       {ECO:0000244|PDB:4BKN}.
SQ   SEQUENCE   570 AA;  61963 MW;  9D6AFE86CBB33AD5 CRC64;
     MSYQGKKNIP RITSDRLLIK GGRIVNDDQS FYADIYMEDG LIKQIGDNLI VPGGVKTIEA
     NGKMVIPGGI DVHTHFQMPY KGMTTVDDFF QGTKAALAGG TTMIIDHVVP EPESSLTEAY
     EKWREWADGK SCCDYALHVD ITHWNDSVKQ EVQNLIKDKG VNSFMVYMAY KDLYQVSNTE
     LYEIFTCLGE LGAIAQVHAE NGDIIAQEQT RMLEMGITGP EGHVLSRPEE LEAEAVFRAI
     TIASQTNCPL YVTKVMSKSA ADLISQARKK GNVVFGEPIT ASLGIDGTHY WSKNWAKAAA
     FVTSPPLSPD PTTPDYINSL LASGDLQLSG SAHCTFSTAQ KAIGKDNFTA IPEGTNGVEE
     RMSVIWDKAV ATGKMDENQF VAVTSTNAAK IFNLYPRKGR ISVGSDSDLV IWDPDAVKIV
     SAKNHQSAAE YNIFEGMELR GAPLVVICQG KIMLEDGNLH VTQGAGRFIP CSPFSDYVYK
     RIKARRKMAD LHAVPRGMYD GPVFDLTTTP KGGTPAGSAR GSPTRPNPPV RNLHQSGFSL
     SGTQVDEGVR SASKRIVAPP GGRSNITSLS
//
